Literature DB >> 3734777

Cerebrospinal fluid concentrations of free GABA in schizophrenia: no changes after haloperidol treatment.

W F Gattaz, E Roberts, H Beckmann.   

Abstract

The concentrations of free GABA were determined in the cerebrospinal fluid of 19 paranoid schizophrenic patients before and after 3 weeks on haloperidol treatment. No significant effect of the neuroleptic treatment on the CSF free GABA concentrations was detected. Furthermore, no correlations were found between changes in GABA concentrations and psychopathological improvement on the Brief Psychiatric Rating Scale. These negative findings are at variance with earlier reports of increased or decreased CSF GABA concentrations after neuroleptics and suggest that subtle changes of the amino acid concentrations in the brain might not be faithfully reflected in the concentrations of its free fraction in the cerebrospinal fluid.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3734777     DOI: 10.1007/bf01262959

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  15 in total

1.  The relationship between GABA concentrations in brain and cerebrospinal fluid.

Authors:  P Böhlen; S Huot; M G Palfreyman
Journal:  Brain Res       Date:  1979-05-11       Impact factor: 3.252

Review 2.  Central synaptic transmission--microelectrophoretic studies.

Authors:  D R Curtis; J M Crawford
Journal:  Annu Rev Pharmacol       Date:  1969       Impact factor: 13.820

3.  Localizing 3H-GABA in nerve terminals of rat cerebral cortex by electron microscopic autoradiography.

Authors:  F E Bloom; L L Iversen
Journal:  Nature       Date:  1971-02-26       Impact factor: 49.962

4.  Prospects for research on schizophrenia. An hypotheses suggesting that there is a defect in the GABA system in schizophrenia.

Authors:  E Roberts
Journal:  Neurosci Res Program Bull       Date:  1972-11

5.  Gamma-aminobutyric acid in the brain in schizophrenia.

Authors:  A J Cross; T J Crow; F Owen
Journal:  Lancet       Date:  1979-03-10       Impact factor: 79.321

6.  Short- and long-term effects of GABA and dopamine neurons during treatment with sulpiride.

Authors:  R Zimmer; A W Teelken; H Cramer; M Ackenheil; K J Zander; H Fischer
Journal:  Adv Biochem Psychopharmacol       Date:  1980

Review 7.  GABA and acute psychoses.

Authors:  B Meldrum
Journal:  Psychol Med       Date:  1982-02       Impact factor: 7.723

8.  Total GABA and homocarnosine in CSF as indices of brain GABA concentrations.

Authors:  M G Palfreyman; S Huot; J Grove
Journal:  Neurosci Lett       Date:  1983-02-21       Impact factor: 3.046

9.  Gamma-aminobutyric acid (GABA) in the CSF of schizophrenic patients before and after neuroleptic treatment.

Authors:  D Lichtshtein; J Dobkin; R P Ebstein; J Biederman; R Rimon; R H Belmaker
Journal:  Br J Psychiatry       Date:  1978-02       Impact factor: 9.319

10.  Glutamic acid decarboxylase and gamma-aminobutyric acid in Huntington's disease fibroblasts and other cultured cells, determined by a [3H]muscimol radioreceptor assay.

Authors:  E Hamel; I E Goetz; E Roberts
Journal:  J Neurochem       Date:  1981-10       Impact factor: 5.372

View more
  2 in total

Review 1.  Clinical relevance of measuring GABA concentrations in cerebrospinal fluid.

Authors:  P J Schechter; A Sjoerdsma
Journal:  Neurochem Res       Date:  1990-04       Impact factor: 3.996

2.  CSF GABA is reduced in first-episode psychosis and associates to symptom severity.

Authors:  F Orhan; H Fatouros-Bergman; M Goiny; A Malmqvist; F Piehl; S Cervenka; K Collste; P Victorsson; C M Sellgren; L Flyckt; S Erhardt; G Engberg
Journal:  Mol Psychiatry       Date:  2017-03-14       Impact factor: 15.992

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.